Fevipiprant
Catalog No. A17244
Fevipiprant, also known as NVP-QAW039 or QAW039, is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment.
| Catalog Num | A17244 |
|---|---|
| M. Wt | 426.4102 |
| Formula | C19H17F3N2O4S |
| Purity | >98% |
| Storage | at -20°C 3 years Powder |
| CAS No. | 872365-14-5 |
| Synonyms | NVP-QAW039; NVP-QAW 039; NVP-QAW-039 QAW-039; QAW039; QAW 039; |
| SMILES | O=C(O)CC1=C(C)N(CC2=CC=C(S(=O)(C)=O)C=C2C(F)(F)F)C3=NC=CC=C31 |
Fevipiprant, also known as NVP-QAW039 or QAW039, is an oral active and potent CRTh2 receptor antagonist and potentially useful for asthma treatment.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 23.45 mL | 117.26 mL | 234.52 mL |
| 0.5 mM | 4.69 mL | 23.45 mL | 46.9 mL |
| 1 mM | 2.35 mL | 11.73 mL | 23.45 mL |
| 5 mM | 0.47 mL | 2.35 mL | 4.69 mL |
*The above data is based on the productmolecular weight 426.4102. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
Contact information
United StatesAdooq Bioscience
Toll Free: (866) 930-6790
Fax: +1-323-606-8156
Email: sales@adooq.com
ADOOQ 产品质量保证
We promise all products to perform as described.